Skip to content

BONE BIOLOGICS CORPORATION: 10-K filed 2018-04-02

What BONE BIOLOGICS CORPORATION reported in its annual report filed 2018-04-02 (fiscal FY 2017): 35 published measures, 234 facts as tagged in accession 0001493152-18-004423.

This filing

Form
10-K (annual report)
Filed
2018-04-02
Fiscal period
fiscal FY 2017
Accession
0001493152-18-004423 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BONE BIOLOGICS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-12-31795,659USD
At 2017-09-301,668,555USD
At 2017-06-30868,389USD
At 2017-03-311,695,881USD
At 2016-12-31701,140USD
At 2016-09-30771,394USD
At 2016-06-302,333,846USD
At 2016-03-314,321,172USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-12-319,191,482USD
At 2017-09-3011,847,632USD
At 2017-06-3010,544,441USD
At 2017-03-319,544,087USD
At 2016-12-319,064,838USD
At 2016-09-307,731,978USD
At 2016-06-307,711,393USD
At 2016-03-317,547,038USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-12-31-8,395,823USD
At 2017-09-30-10,179,077USD
At 2017-06-30-9,676,052USD
At 2017-03-31-7,848,206USD
At 2016-12-31-8,363,698USD
At 2016-09-30-6,960,584USD
At 2016-06-30-5,377,547USD
At 2016-03-31-3,225,866USD
At 2015-12-31-4,197,919USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-12-31690,279USD
At 2017-09-301,621,979USD
At 2017-06-30783,014USD
At 2017-03-311,612,336USD
At 2016-12-31620,375USD
At 2016-09-30688,233USD
At 2016-06-302,194,325USD
At 2016-03-314,221,188USD
At 2015-12-311,115,109USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-7,051,572USD365
2007-10-18 to 2017-12-31-59,000,000USD3728
2017-07-01 to 2017-09-30-2,375,739USD92
2017-01-01 to 2017-09-30-4,281,963USD273
2017-04-01 to 2017-06-301,016,301USD91
2017-01-01 to 2017-06-30-1,906,224USD181
2017-01-01 to 2017-03-31-2,922,526USD90
2016-01-01 to 2016-12-31-25,878,675USD366
2016-07-01 to 2016-09-30-4,220,591USD92
2016-01-01 to 2016-09-30-21,180,390USD274
2016-04-01 to 2016-06-30-4,696,010USD91
2016-01-01 to 2016-06-30-16,959,799USD182
2016-01-01 to 2016-03-31-12,263,789USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-3,330,096USD365
2017-01-01 to 2017-09-30-2,398,396USD273
2017-01-01 to 2017-06-30-1,837,361USD181
2017-01-01 to 2017-03-31-1,008,039USD90
2016-01-01 to 2016-12-31-7,327,845USD366
2016-01-01 to 2016-09-30-6,059,987USD274
2016-01-01 to 2016-06-30-4,553,895USD182
2016-01-01 to 2016-03-31-2,527,032USD91

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2007-10-18 to 2017-12-311,070,000,000USD3728

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-12-313,400,000USD365
2017-01-01 to 2017-09-303,400,000USD273
2017-01-01 to 2017-06-302,000,000USD181
2017-01-01 to 2017-03-312,000,000USD90
2016-01-01 to 2016-12-316,833,111USD366
2016-01-01 to 2016-09-305,633,111USD274
2016-01-01 to 2016-06-305,633,111USD182
2016-01-01 to 2016-03-315,633,111USD91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-12-31-59,185,022USD
At 2017-09-3056,415,412USD
At 2017-06-3054,039,673USD
At 2017-03-3155,055,975USD
At 2016-12-31-52,133,450USD
At 2016-09-3047,435,166USD
At 2016-06-3043,214,575USD
At 2016-03-3138,518,566USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-04-01 to 2017-06-3038,828,607shares91

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-04-01 to 2017-06-3040,747,260shares91

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-04-01 to 2017-06-300.03USD/shares91

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-04-01 to 2017-06-300.02USD/shares91

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-01-01 to 2017-12-311,600USD365
2017-01-01 to 2017-09-301,600USD273
2017-04-01 to 2017-06-301,600USD91
2017-01-01 to 2017-06-301,600USD181
2016-01-01 to 2016-12-312,243USD366
2016-07-01 to 2016-09-301,010USD92
2016-01-01 to 2016-09-302,745USD274
2016-01-01 to 2016-06-301,600USD182
2016-01-01 to 2016-03-311,600USD91

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-12-31146USD
At 2017-09-30170USD
At 2017-06-30194USD
At 2017-03-31218USD
At 2016-12-31242USD
At 2016-09-30282USD
At 2016-06-30322USD
At 2016-03-31362USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-01-01 to 2017-12-312,160,722USD365
2017-01-01 to 2017-09-301,405,396USD273
2017-01-01 to 2017-06-301,038,239USD181
2017-01-01 to 2017-03-31507,768USD90
2016-01-01 to 2016-12-314,143,729USD366
2016-01-01 to 2016-09-302,938,825USD274
2016-01-01 to 2016-06-301,939,157USD182
2016-01-01 to 2016-03-31924,586USD91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-2,626,592USD365
2017-07-01 to 2017-09-30-1,130,776USD92
2017-01-01 to 2017-09-30-1,315,986USD273
2017-04-01 to 2017-06-301,974,963USD91
2017-01-01 to 2017-06-30-185,211USD181
2017-01-01 to 2017-03-31-2,160,174USD90
2016-01-01 to 2016-12-31-20,412,278USD366
2016-07-01 to 2016-09-30-3,857,415USD92
2016-01-01 to 2016-09-30-17,298,040USD274
2016-04-01 to 2016-06-30-4,336,102USD91
2016-01-01 to 2016-06-30-13,440,760USD182
2016-01-01 to 2016-03-31-9,104,658USD91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-12-31795,513USD
At 2017-09-301,668,385USD
At 2017-06-30868,195USD
At 2017-03-311,695,663USD
At 2016-12-31700,898USD
At 2016-09-30771,112USD
At 2016-06-302,333,524USD
At 2016-03-314,320,810USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-07-01 to 2017-09-301,244,963USD92
2017-04-01 to 2017-06-30957,062USD91
2017-01-01 to 2017-03-31762,352USD90
2016-07-01 to 2016-09-30362,166USD92
2016-04-01 to 2016-06-30359,908USD91
2016-01-01 to 2016-03-31310,089USD91

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-12-31961,795USD
At 2017-09-303,819,607USD
At 2017-06-302,683,087USD
At 2017-03-311,814,399USD
At 2016-12-311,501,816USD
At 2016-09-30335,622USD
At 2016-06-30481,703USD
At 2016-03-31484,014USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-12-31216,903USD
At 2016-12-31226,516USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-01-01 to 2017-12-312,626,592USD365
2017-07-01 to 2017-09-301,130,776USD92
2017-01-01 to 2017-09-301,315,986USD273
2017-04-01 to 2017-06-30-1,974,963USD91
2017-01-01 to 2017-06-30185,211USD181
2017-01-01 to 2017-03-312,160,174USD90
2016-01-01 to 2016-12-3120,412,278USD366
2016-07-01 to 2016-09-303,857,415USD92
2016-01-01 to 2016-09-3017,298,040USD274
2016-04-01 to 2016-06-304,336,102USD91
2016-01-01 to 2016-06-3013,440,760USD182
2016-01-01 to 2016-03-319,104,658USD91

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-1,193,567USD365
2017-07-01 to 2017-09-30248,377USD92
2017-01-01 to 2017-09-30-1,654,074USD273
2017-04-01 to 2017-06-30-3,093,863USD91
2017-01-01 to 2017-06-30-1,902,450USD181
2017-01-01 to 2017-03-311,191,412USD90
2016-01-01 to 2016-12-3110,167,776USD366
2016-07-01 to 2016-09-302,473,433USD92
2016-01-01 to 2016-09-309,470,369USD274
2016-04-01 to 2016-06-302,318,735USD91
2016-01-01 to 2016-06-306,996,936USD182
2016-01-01 to 2016-03-314,678,201USD91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-12-3143,280,795shares
At 2016-12-3138,828,607shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-12-3148,922,842USD
At 2017-09-3044,374,196USD
At 2017-06-3042,501,715USD
At 2017-03-3145,345,863USD
At 2016-12-3141,907,846USD
At 2016-09-3038,612,676USD
At 2016-06-3035,975,122USD
At 2016-03-3133,431,540USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-12-31503USD
At 2016-12-31503USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-12-31357USD
At 2016-12-31261USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-01-01 to 2017-12-313,820,159USD365
2017-07-01 to 2017-09-30882,399USD92
2017-01-01 to 2017-09-302,970,060USD273
2017-04-01 to 2017-06-301,118,900USD91
2017-01-01 to 2017-06-302,087,661USD181
2017-01-01 to 2017-03-31968,762USD90
2016-01-01 to 2016-12-315,653,475USD366
2016-07-01 to 2016-09-301,383,982USD92
2016-01-01 to 2016-09-307,827,671USD274
2016-04-01 to 2016-06-302,017,367USD91
2016-01-01 to 2016-06-306,443,824USD182
2016-01-01 to 2016-03-314,426,457USD91

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-01-01 to 2017-12-3196USD365
2017-01-01 to 2017-09-3072USD273
2017-01-01 to 2017-06-3048USD181
2017-01-01 to 2017-03-3124USD90
2016-01-01 to 2016-12-31700USD366
2016-01-01 to 2016-09-30660USD274
2016-01-01 to 2016-06-30620USD182
2016-01-01 to 2016-03-31580USD91

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2016-01-01 to 2016-09-30-4,862USD274
2016-01-01 to 2016-06-30-4,862USD182
2016-01-01 to 2016-03-31-4,862USD91

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-4,423,380USD365
2017-07-01 to 2017-09-30-1,244,963USD92
2017-01-01 to 2017-09-30-2,964,377USD273
2017-04-01 to 2017-06-30-957,062USD91
2017-01-01 to 2017-06-30-1,719,413USD181
2017-01-01 to 2017-03-31-762,352USD90
2016-01-01 to 2016-12-31-5,464,154USD366
2016-07-01 to 2016-09-30-362,166USD92
2016-01-01 to 2016-09-30-3,879,605USD274
2016-04-01 to 2016-06-30-359,908USD91
2016-01-01 to 2016-06-30-3,517,439USD182
2016-01-01 to 2016-03-31-3,157,531USD91

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2017-01-01 to 2017-12-311,600USD365
2016-01-01 to 2016-12-312,243USD366

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2017-01-01 to 2017-12-31516,375USD365
2017-01-01 to 2017-09-30516,375USD273
2017-01-01 to 2017-06-30436,192USD181
2017-01-01 to 2017-03-31191,250USD90
2016-01-01 to 2016-12-31751,306USD366
2016-01-01 to 2016-09-30555,805USD274
2016-01-01 to 2016-06-30360,306USD182
2016-01-01 to 2016-03-31166,931USD91

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2017-01-01 to 2017-12-311,600USD365
2017-01-01 to 2017-09-301,600USD273
2017-01-01 to 2017-06-301,600USD181
2016-01-01 to 2016-12-312,243USD366
2016-01-01 to 2016-09-302,745USD274
2016-01-01 to 2016-06-301,600USD182
2016-01-01 to 2016-03-311,600USD91

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2017-01-01 to 2017-12-31700,000USD365
2017-01-01 to 2017-09-30700,000USD273
2017-08-17 to 2017-08-18700,000USD2
2016-01-01 to 2016-12-312,500,000USD366
2016-01-01 to 2016-09-302,500,000USD274
2016-01-01 to 2016-06-302,500,000USD182
2016-01-01 to 2016-03-312,500,000USD91

Inspect the source

Entity
BONE BIOLOGICS CORPORATION / CIK 0001419554
Captured
2026-09-20T08:02:52.100Z
SEC response SHA-256
7c2684db7febb4ea6b03577e138dc91ed20e12534f1d96c178894d4b68a7b815

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001419554.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))